Trends in Reports of Statin-Associated Immune-Mediated Necrotizing Myopathy Using the Japanese Adverse Drug Event Report Database [0.03%]
日本不良事件数据库中他汀类药物相关免疫介导的坏死性肌病报告的特征及趋势分析
Akina Takami,Gen Terashima,Takumi Tajima et al.
Akina Takami et al.
Background: In October 2016, precautions of the package inserts for ethical drugs containing statins were revised for immune-mediated necrotizing myopathy (IMNM). ...
Characteristics of Patients with Hereditary Angioedema Who Reduced Lanadelumab Treatment Administration Frequency: A Retrospective Observational Study of US Claims Data [0.03%]
一项基于美国理赔数据的回顾性观察研究：减少拉那雷卢姆治疗给药频率的遗传性血管水肿患者的特征
Nicole Princic,Kristin A Evans,Chintal H Shah et al.
Nicole Princic et al.
Background: Lanadelumab is the only long-term prophylaxis indicated for reduced administration frequency in patients with hereditary angioedema who have been well controlled for > 6 months. Understanding the characteristi...
Lipid-Lowering Efficiency and Safety of Alirocumab 300 mg Using a 2-mL Autoinjector Device in Real-World Practice: The MARS Study [0.03%]
300毫克阿利库姆单抗使用2毫升自动注射器装置降低血脂的有效性和安全性：火星研究
Klaus G Parhofer,Peter Bramlage,Constanze Gries et al.
Klaus G Parhofer et al.
Background: Alirocumab is a fully human monoclonal antibody to proprotein convertase subtilisin kexin type 9 used for the reduction of low-density lipoprotein cholesterol (LDL-C) in high-risk patients not reaching their L...
Comparative Efficacy of Lenvatinib Plus Immunotherapy and Regorafenib Plus Immunotherapy After Lenvatinib Failure for Advanced Hepatocellular Carcinoma: A Retrospective Study [0.03%]
仑伐替尼失败后免疫治疗联合乐伐替尼与瑞戈非尼的疗效：回顾性研究
Zeyu Yu,Bin Leng,Ran You et al.
Zeyu Yu et al.
Background: The combination of regorafenib and immune checkpoint inhibitor (ICI) has been the most popular second-line systemic therapy for advanced hepatocellular carcinoma (HCC). However, considering the good anti-tumor...
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA [0.03%]
美国难治性抑郁症患者使用艾斯氯胺酮鼻喷雾剂与传统治疗相关的缺勤时长及成本分析
Manish K Jha,Maryia Zhdanava,Aditi Shah et al.
Manish K Jha et al.
Introduction: Treatment-resistant depression (TRD) is related to disproportionate unemployment and productivity burden in the USA. The current study describes real-world mental health (MH)-related disability days and cost...
Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study [0.03%]
英夫利西生物类似药SB5在风湿病和胃肠道免疫介导的炎症性疾病中的临床结局的真实世界证据：PERFUSE研究的12个月数据的更正通知
Bruno Fautrel,Yoram Bouhnik,Carine Salliot et al.
Bruno Fautrel et al.
Published Erratum
Drugs - real world outcomes. 2025 Jan 16. DOI:10.1007/s40801-024-00477-4 2025
Effectiveness and Safety of Vildagliptin Sustained Release in the Management of Type 2 Diabetes Mellitus: Real-World Evidence in Indian Patients [NOVELTY Study] [0.03%]
维格列汀缓释片治疗2型糖尿病的疗效和安全性：印度患者的现实世界证据[新颖性研究]
Rakesh Sahay,Anil Bhansali,Surendra Kumar Sharma et al.
Rakesh Sahay et al.
Background and objective: Vildagliptin sustained release (XR), a formulation that provides vildagliptin 100 mg with a once-daily dose administration, is a recent introduction to manage type 2 diabetes mellitus in India. T...
Patients' Health-Related Quality of Life and Use of Medicinal Cannabis: A Cross-Sectional Survey Study [0.03%]
患者使用医用大麻及其对健康相关生命质量的影响：横断面调查研究
Frederik Rosenbæk,Sonja Wehberg,Line Bjørnskov Pedersen et al.
Frederik Rosenbæk et al.
Background: Studies on medicinal cannabis (MC) have primarily investigated effects on diseases and symptoms, while there is only sparse knowledge on patients' health-related quality of life. Our aim was, firstly, to compa...
Medication Hazards and Outcome Patterns of Pediatric Drug-Associated Liver Injury in Taiwan: An Analysis of 1998-2017 Spontaneous Adverse Drug Reaction Reports [0.03%]
台湾1998至2017年儿童药物性肝损伤的自发报告分析：危害及结局模式分析
Yu-Ting Huang,Yen-Ming Huang,Ni-Chung Lee et al.
Yu-Ting Huang et al.
Background and objectives: Accumulating pediatric efficacy and safety data on drug use is inherently challenging yet essential. This study aimed to analyze the frequency and compute the odds of pediatric drug-associated l...
Correction: Falls and Fractures Among Nursing Home Residents Treated with Pimavanserin Versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis [0.03%]
关于普维马南辛与其他非典型抗精神病药物治疗的养老院帕金森病精神病患者跌倒和骨折情况的更正：基于Medicare参保者的分析
Krithika Rajagopalan,Nazia Rashid,Daksha Gopal et al.
Krithika Rajagopalan et al.
Published Erratum
Drugs - real world outcomes. 2025 Jan 7. DOI:10.1007/s40801-024-00476-5 2025